← All stories
Markets
Haleon (HLN) Launches $2 Billion Three-Tranche USD Bond to Refinance 2027 Maturities
Haleon plc (LSE/NYSE: HLN), the consumer health giant behind brands like Sensodyne, Panadol, and Advil, has priced a $2 billion SEC-registered bond issuance via its wholly-owned subsidiary Haleon US Capital LLC. Announced on 12 August 2026,…
Covered by 1 outlet
All coverage · 1 article